Hospitals and generic drugmakers have join big pharma lobbyists who have said such trade barriers will cause shortages of ...

The start of Donald Trump’s second presidency and Republican control in the 119th Congress raises questions about the future ...

Repatha: the frontline of US price battles Amgen's Repatha became the first in the new class of cholesterol-lowering PCSK9 inhibitor drugs to gain approval this year, getting the nod in Europe in ...

The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower ...

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for Medicare price negotiations for 2027, the U.S. government said on Friday, part of ...

Over $600 billion in European goods were imported by the U.S. last year. New tariffs from President Trump will likely hit ...

Your guide to what the 2024 US election means for Washington and the world Prices ... in Europe by market capitalisation. Its shares dropped 4.3 per cent to DKr575.6 ($79.33). The group of drugs ...

Unlike opium, nitazenes and other synthetic opioids can be produced anywhere in the world using precursor chemicals that are often uncontrolled.

The prices of patented, brand-name drugs are monitored by the federal ... reliant on other countries like the United States, India and European nations for active pharmaceutical ingredients ...

President Trump’s tariffs in China are in place and hitting all products imported from the country — including a number of pharmaceutical drugs that Americans rely upon. Chinese imports ...

From the base ingredients to the finished products, US medicines rely on a global supply chain that is already stressed and ...

The US plans to slash the price it pays for the Novo Nordisk A ... of a higher dose of Wegovy disappointed investors and European drug regulators said they were investigating cases of a rare ...